AVANOS Investor Contact: Michael Greiner Avanos Medical, Inc. 470-562-2692 Investor.Relations@Avanos.com Media Contact: Katrine Kubis Avanos Medical, Inc. CorporateCommunications@Avanos.com Avanos Medical, Inc. Announces First Quarter 2024 Results ALPHARETTA, Ga., May 2, 2024/PRNewswire/ -- Avanos Medical, Inc. (NYSE: AVNS) today reported first quarter 2024 financial results. "As we begin the second year of our three-year transformation initiative, we are pleased with our first quarter results," said Joe Wo ...

ALPHARETTA, Ga., April 25, 2024 /PRNewswire/ -- Avanos Medical, Inc. (NYSE: AVNS) will webcast its conference call discussing financial results and business highlights for the first quarter 2024 on Thursday, May 2 at 9 a.m., ET. The company will issue a news release detailing its results before the market opens that same day.The conference call will be hosted by Joe Woody, chief executive officer, and Michael Greiner, senior vice president, chief financial officer, and chief transformation officer.To join t ...

Avanos Medical, Inc. (AVNS) is well-poised for growth in the coming quarters, courtesy of its impressive product line. The optimism led by a solid fourth-quarter 2023 performance and continued focus on its research and development (R&D) are expected to contribute further. However, stiff competition and macroeconomic concerns persist.Over the past year, this Zacks Rank #3 (Hold) stock has lost 33.9% against the 9.8% rise of the industry and 27.6% growth of the S&P 500 Composite.The renowned medical device so ...

ALPHARETTA, Ga., Feb. 21, 2024 /PRNewswire/ -- In direct response to the Nurse Assist, LLC voluntary recall of pre-filled syringes and other sterile water products, Avanos Medical, Inc. (NYSE: AVNS) voluntarily recalled specific lots of MIC* Gastric – Jejunal Feeding Tube Kits on Jan. 16, 2024. These kits include Nurse Assist supplied syringes, pre-filled with sterile water, essential for inflating the retention balloon of the feeding tube. The Nurse Assist voluntary recall was initiated due to concerns abo ...

Avanos Medical, Inc. (AVNS) reported fourth-quarter 2023 adjusted earnings per share (EPS) from continuing operations of 36 cents, down 20% year over year. The bottom line missed the Zacks Consensus Estimate by a penny.GAAP EPS from continuing operations in the quarter under review was 24 cents, up 14.3% year over year.Full-year adjusted EPS was $1.03, up 3% compared with that at the end of the comparable 2022 period. The figure lagged the Zacks Consensus Estimate by 0.9%.RevenuesRevenues grossed $173.3 mil ...

Avanos Medical, Inc. (NYSE:AVNS) Q4 2023 Earnings Conference Call February 20, 2024 9:00 AM ET Company Participants Scott Galovan - Senior Vice President, Strategy & Corporate Development Joe Woody - Chief Executive Officer Michael Greiner - Senior Vice President, Chief Financial Officer & Chief Transformation Officer Conference Call Participants Daniel Stauder - JMP Securities Rick Wise - Stifel Kristen Stewart - CL King Operator Good day and welcome to the Avanos Fourth Quarter and Full Year 2023 Earnings ...

UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 10-K (Mark One) ☒ Annual Report Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 For the fiscal year ended December 31, 2023 OR ☐ Transition Report Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 For the transition period from to Commission file number: 001-36440 Avanos Medical, Inc. (Exact name of registrant as specified in its charter) Delaware 46-4987888 (State or other jurisdiction o ...

Q4 2023 Earnings Presentation February 20th, 2024 Getting patients back to the things that matter. Joe Woody Michael Greiner Chief Executive Officer Senior Vice President, CFO & Chief Transformation Officer ...

ALPHARETTA, Ga., Feb. 13, 2024 /PRNewswire/ -- Avanos Medical, Inc. (NYSE: AVNS) will webcast its conference call discussing financial results and business highlights for the fourth quarter and full year 2023 on Tuesday, Feb. 20 at 9 a.m., ET. The company will issue a news release detailing its results before the market opens that same day.The conference call will be hosted by Joe Woody, chief executive officer, and Michael Greiner, senior vice president and chief financial officer.To join the live conferen ...

Q3 2023 Earnings Presentation November 1st, 2023 Getting patients back to the things that matter. Joe Woody Michael Greiner Chief Executive Officer Senior Vice President, CFO & Chief Transformation Officer ...